CLDI icon

Calidi Biotherapeutics
CLDI

Overview Fund Activity

25 hedge funds and large institutions have $40.6M invested in Calidi Biotherapeutics in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 5 closing their positions.

Holders
25
Holders Change
-2
Holders Change %
-7.41%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
3
Increased
4
Reduced
3
Closed
5
Calls
–
Puts
$2.26M
Net Calls
-$2.26M
Net Calls Change
-$2.88M

Top Buyers

1
CS
1
Clear Street
New York
$2.25M
2
QL
2
Quarry LP
New York
$1.68M
3
SFM
3
Spartan Fund Management
Canada
$3.2M
4
BFM
4
Boothbay Fund Management
New York
$461K
5
ASM
5
ATW SPAC Management
New York
$441K

Top Sellers

1
GCL
1
Glazer Capital LLC
New York
$0
2
SCM
2
Shaolin Capital Management
Florida
$0
3
AA
3
AQR Arbitrage
Connecticut
$424K
4
VF
4
Virtu Financial
New York
$0
5
E
5
Ergoteles
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
GCL
26
Glazer Capital LLC
New York
– – -374,900 Closed
SCM
27
Shaolin Capital Management
Florida
– – -200,000 Closed
VF
28
Virtu Financial
New York
– – -30,368 Closed
E
29
Ergoteles
New York
– – -19,066 Closed
DFCM
30
Dark Forest Capital Management
Puerto Rico
– – -2,000 Closed
PP
31
Paloma Partners
Connecticut
– – – –
CFGS
32
Concourse Financial Group Securities
Alabama
– – – –
1
2